Jonathan Uy

853 citations

24 papers · 532 indexed · h-index 10

Impact in

Virology top 2%
- HIV Research and Treatment
Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions

Papers in ⓘ

Virology 8
- HIV Research and Treatment 8
Infectious Diseases 11
- HIV/AIDS drug development and treatment 10
- HIV/AIDS Research and Interventions 9

Co-authors: Tracy Lessor (1 shared paper)Hillel P. Cohen (1 shared paper)Michael Muenzberg (1 shared paper)David Chien (1 shared paper)Dorothy McCabe (1 shared paper)Robert Popovian (1 shared paper)Michael J. Kozal (3 shared papers)Victoria Wirtz (3 shared papers)
Journals: Dermatology and Therapy (3 papers)Journal of the American Academy of Dermatology (2 papers)Advances in Therapy (2 papers)Antiviral Therapy (2 papers)The Journal of Urology (2 papers)
Partner nations: United States Belgium Germany

In The Last Decade

Jonathan Uy

23 papers receiving 518 citations

Peers

Countries citing papers authored by Jonathan Uy

Since Specialization

Citations

This map shows the geographic impact of Jonathan Uy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Uy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Uy more than expected).

Fields of papers citing papers by Jonathan Uy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Uy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Uy. The network helps show where Jonathan Uy may publish in the future.

Co-authors

The 25 scholars most cited alongside Jonathan Uy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jonathan Uy Line = papers co-authored together Jonathan Uy links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Awareness, Knowledge, and Perceptions of Biosimilars Among Specialty Physicians Advances in Therapy ·Hillel P. Cohen, Donna Beydoun, David Chien, Tracy Lessor, Dorothy McCabe, Michael Muenzberg, Robert Popovian, Jonathan Uy	2016	162
2	Prevalence and Clinical Significance of HIV Drug Resistance Mutations by Ultra-Deep Sequencing in Antiretroviral-Naïve Subjects in the CASTLE Study PLoS ONE ·Max Lataillade, Jennifer Chiarella, Rong Yang, Steven Schnittman, Victoria Wirtz, Jonathan Uy, Daniel Seekins, Mark Krystal, Marco Mancini, Donnie McGrath, Birgitte B. Simen, Michael D. Miller, Michael J. Kozal	2010	101
3	Initiation of HAART at Higher CD4 Cell Counts Is Associated With a Lower Frequency of Antiretroviral Drug Resistance Mutations at Virologic Failure JAIDS Journal of Acquired Immune Deficiency Syndromes ·Jonathan Uy, Carl Armon, Kate Buchacz, Kathy Wood, John T. Brooks	2009	43
4	The Incidence of HIV Drug Resistance and Its Impact on Progression of HIV Disease Among Antiretroviral-Naïve Participants Started on Three Different Antiretroviral Therapy Strategies HIV Clinical Trials ·Michael J. Kozal, Katherine Huppler Hullsiek, Rodger D. MacArthur, Mary van den Berg-Wolf, Grace Peng, Ying Xiang, John D. Baxter, Jonathan Uy, Edward E. Telzak, Richard M. Novak, (unknown)	2007	41
5	Virologic Failures on Initial Boosted-PI Regimen Infrequently Possess Low-Level Variants with Major PI Resistance Mutations by Ultra-Deep Sequencing PLoS ONE ·Max Lataillade, Jennifer Chiarella, Rong Yang, Michelle DeGrosky, Jonathan Uy, Daniel Seekins, Birgitte B. Simen, Elizabeth St. John, Elizabeth Moreno, Michael J. Kozal	2012	31
6	CYP2C19 Genotype-Dependent Pharmacokinetic Drug Interaction Between Voriconazole and Ritonavir-Boosted Atazanavir in Healthy Subjects The Journal of Clinical Pharmacology ·Li Zhu, Roger J. M. Brüggemann, Jonathan Uy, Angela Colbers, Matthew Hruska, Ellen Chung, Karen Sims, Blisse Vakkalagadda, Xiaohui Xu, Ron H. N. van Schaik, David M. Burger, Richard Bertz	2016	26
7	Clinical Significance of Hyperbilirubinemia Among HIV-1–Infected Patients Treated with Atazanavir/Ritonavir Through 96 Weeks in the CASTLE Study AIDS Patient Care and STDs ·Cheryl McDonald, Jonathan Uy, Wenhua Hu, Victoria Wirtz, Salomé Juethner, D. Butcher, Donnie McGrath, Awny Farajallah, Graeme Moyle	2012	25
8	Efficacy of Avanafil 15 Minutes after Dosing in Men with Erectile Dysfunction: A Randomized, Double-Blind, Placebo Controlled Study The Journal of Urology ·Wayne J.G. Hellstrom, Jed Kaminetsky, Laurence Belkoff, Irwin Goldstein, James P. Tursi, Jonathan Uy, Craig A. Peterson, Charles H. Bowden, Wesley Day	2015	24
9	Phenotypic and Genotypic Analysis of Biologically Cloned Human Immunodeficiency Virus Type 1 Isolates from Patients Treated with Zidovudine and Lamivudine Antimicrobial Agents and Chemotherapy ·Thomas C. Stoeckli, Samantha MaWhinney, Jonathan Uy, Chengying Duan, Jing Lü, David Shugarts, Daniel R. Kuritzkes	2002	21
10	Cost effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in treatment-naïve human immunodeficiency virus-infected patients in the United States Journal of Medical Economics ·Michael S. Broder, Eunice Chang, Tanya G. K. Bentley, Timothy Juday, Jonathan Uy	2011	10
11	Outcomes of Second Combination Antiretroviral Therapy Regimens Among HIV-Infected Persons in Clinical Care: A Multicenter Cohort Study AIDS Research and Human Retroviruses ·Sonia Napravnik, Joseph J. Eron, Timothy R. Sterling, Timothy Juday, Jonathan Uy, Richard D. Moore	2012	9
12	Signal Detection and Methodological Limitations in a Real-World Registry: Learnings from the Evaluation of Long-Term Safety Analyses in PSOLAR Drug Safety ·Robert Bissonnette, Alice B. Gottlieb, Richard G. Langley, Craig L. Leonardi, Kim Papp, David M. Pariser, Jonathan Uy, Kim Parnell Lafferty, Wayne Langholff, Steven Fakharzadeh, Jesse A. Berlin, Emily Brouwer, Andrew Greenspan, Bruce Strober	2021	8
13	Comparative Incidence and Health Care Costs of Medically Attended Adverse Effects among U.S. Medicaid HIV Patients on Atazanavir- or Darunavir-Based Antiretroviral Therapy Value in Health ·Stephen S. Johnston, Timothy Juday, Stephen Esker, Derek Espindle, Bong-Chul Chu, Tony Hebden, Jonathan Uy	2013	7
14	The Effectiveness of Guselkumab by BMI Category Among Patients with Moderate-to-Severe Plaque Psoriasis in the CorEvitas Psoriasis Registry Advances in Therapy ·April W. Armstrong, Timothy Fitzgerald, Robert R. McLean, Amanda Teeple, Jonathan Uy, Mobolaji Olurinde, Katelyn Rowland, Lin Guo, Ying Shan, Kristina Callis Duffin	2023	5
15	Effectiveness of Guselkumab Therapy among Patients with Plaque Psoriasis with Baseline IGA Score ≥ 2 in the CorEvitas Psoriasis Registry Dermatology and Therapy ·April W. Armstrong, Timothy Fitzgerald, Robert R. McLean, Amanda Teeple, Jonathan Uy, Mobolaji Olurinde, Katelyn Rowland, Lin Guo, Ying Shan, Kristina Callis Duffin	2022	4
16	Demographics, Disease Characteristics, and Patient-Reported Outcomes Among Patients with Psoriasis Who Initiated Guselkumab in CorEvitas’ Psoriasis Registry Dermatology and Therapy ·Jessica A. Walsh, Kristina Callis Duffin, Abby S. Van Voorhees, Soumya D. Chakravarty, Timothy Fitzgerald, Amanda Teeple, Katelyn Rowland, Jonathan Uy, Robert R. McLean, Wendi Malley, Angel M. Cronin, Joseph F. Merola	2021	4
17	Treatment of advanced HIV disease in antiretroviral-naïve HIV-1-infected patients receiving once-daily atazanavir/ritonavir or twice-daily lopinavir/ritonavir, each in combination with tenofovir disoproxil fumarate and emtricitabine AIDS Care ·Jonathan Uy, Rong Yang, Victoria Wirtz, Louise Sheppard, Awny Farajallah, Donnie McGrath	2011	3
18	Real-World Effectiveness of 9–12 Months of Guselkumab Therapy among Patients with Moderate-to-Severe Plaque Psoriasis in the CorEvitas Psoriasis Registry Dermatology and Therapy ·April W. Armstrong, Timothy Fitzgerald, Robert R. McLean, Amanda Teeple, Jonathan Uy, Mobolaji Olurinde, Katelyn Rowland, Lin Guo, Ying Shan, Kristina Callis Duffin	2022	2
19	HIV Genotypic Resistance Testing to Optimize Antiretroviral Prescribing: Is There Room for Improvement? Antiviral Therapy ·Jonathan Uy, John T. Brooks, Rose Baker, Mark A. Hoffman, Anne C. Moorman, Richard Novák, (unknown)	2007	2
20	25696 Impact of guselkumab on quality of life and work productivity outcomes among patients with moderate-to severe plaque psoriasis in the Corrona Psoriasis Registry Journal of the American Academy of Dermatology ·April W. Armstrong, Kristina Callis-Duffin, Timothy Fitzgerald, Amanda Teeple, Jonathan Uy, Mobolaji Olurinde, Katelyn Rowland, Robert R. McLean, Lin Guo, Ying Shan, Abby S. Van Voorhees	2021	1

About Jonathan Uy

Jonathan Uy is a scholar working on Virology, Infectious Diseases, Emergency Medicine, Immunology and Toxicology, having authored 24 papers that have together received 532 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (10 papers), HIV/AIDS Research and Interventions (9 papers), HIV Research and Treatment (8 papers), Psoriasis: Treatment and Pathogenesis (6 papers), HIV-related health complications and treatments (4 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Dermatology and Skin Diseases (2 papers) and Sexual function and dysfunction studies (2 papers). The work is most often cited by research in Virology (222 citations), Infectious Diseases (280 citations), Immunology (176 citations), Pediatrics, Perinatology and Child Health (81 citations) and Economics and Econometrics (108 citations). Jonathan Uy has collaborated with scholars based in United States, Belgium and Germany. Frequent co-authors include Tracy Lessor, Hillel P. Cohen, Michael Muenzberg, David Chien, Dorothy McCabe, Robert Popovian, Michael J. Kozal, Victoria Wirtz, Donnie McGrath and Max Lataillade. Their work appears in journals such as Dermatology and Therapy, Journal of the American Academy of Dermatology, Advances in Therapy, Antiviral Therapy and The Journal of Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact